Background: No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT). Methods: In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions. Results: Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse. Conclusions: The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica / G.L. Banna, N. Nicolai, G. Palmieri, M. Ottaviano, L. Balzarini, D. Barone, U. Basso, A. Bavila, F. Bertoni, F. Calliada, T. Cai, G. Carrafiello, C. Condello, L. Da Pozzo, D. Di Nardo, G. Fornarini, T. Prayer Galetti, A. Garolla, P. Giannatempo, L. Guerra, S. La Spina, L. Malatino, A. Marchiano', M. Monti, F.F. Morbiato, F. Morelli, F. Nole', S. Palazzi, G. Procopio, G. Rosti, C. Sacco, A. Salvetti, R. Salvioni, T. Sava, S. Secondino, S. Serpentini, C. Spreafico, I.M. Tavolini, F. Valcamonico, E. Verri, P. Zucali, U. De Giorgi. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 137(2019), pp. 154-164. [10.1016/j.critrevonc.2019.03.006]
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica
D. Barone;T. Cai;G. Carrafiello;P. Giannatempo;A. Marchiano';S. Palazzi;G. Procopio;S. Secondino;F. Valcamonico;U. De Giorgi
2019
Abstract
Background: No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT). Methods: In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions. Results: Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse. Conclusions: The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1040842819300587-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
303.26 kB
Formato
Adobe PDF
|
303.26 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.